ММВБ 4 248 -0,3%  Nasdaq 15 022 0,8%  Биткойн 61 888 -0,2%  USD/RUB 71,0668 -0,2% 
РТС 1 877 -0,8%  S&P500 4 486 0,3%  Нефть 84,5 0,4%  EUR/RUB 82,7345 0,0% 
Dow 35 259 -0,1%  FTSE100 7 204 -0,4%  Золото 1 773 0,5%  EUR/USD 1,1643 0,3% 

DiaMedica Therapeutics Inc Registered Shs - Профиль

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Акционеры

Название Доля (%)
Freefloat59,06
Trill AB13,58
TomEnterprise AB13,58
Laurence W. Lytton7,35
Hermeda Industrial Co., Ltd.4,94
Vanguard Group, Inc. (Subfiler)4,13
Nantahala Capital Management LLC4,04
Manatuck Hill Partners LLC3,04
Point72 Asset Management LP (Old)2,94
Vanguard Total Stock Market Index Fund2,69
Stonepine Capital Management LLC2,24
Ikarian Capital LLC2,21
Maven Investment Partners US Ltd.1,92
CVI Holdings LLC1,47
Jacob Asset Management of New York LLC1,46

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент